These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33593467)

  • 1. Effects of trypanocidal drugs on DNA synthesis: new insights into melarsoprol growth inhibition.
    Larson S; Carter M; Hovel-Miner G
    Parasitology; 2021 Sep; 148(10):1143-1150. PubMed ID: 33593467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Trypanosoma brucei ORFeome-Based Gain-of-Function Library Identifies Genes That Promote Survival during Melarsoprol Treatment.
    Carter M; Gomez S; Gritz S; Larson S; Silva-Herzog E; Kim HS; Schulz D; Hovel-Miner G
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33028684
    [No Abstract]   [Full Text] [Related]  

  • 3. Overexpression of the putative thiol conjugate transporter TbMRPA causes melarsoprol resistance in Trypanosoma brucei.
    Shahi SK; Krauth-Siegel RL; Clayton CE
    Mol Microbiol; 2002 Mar; 43(5):1129-38. PubMed ID: 11918801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positively selected modifications in the pore of TbAQP2 allow pentamidine to enter
    Alghamdi AH; Munday JC; Campagnaro GD; Gurvic D; Svensson F; Okpara CE; Kumar A; Quintana J; Martin Abril ME; Milić P; Watson L; Paape D; Settimo L; Dimitriou A; Wielinska J; Smart G; Anderson LF; Woodley CM; Kelly SPY; Ibrahim HM; Hulpia F; Al-Salabi MI; Eze AA; Sprenger T; Teka IA; Gudin S; Weyand S; Field M; Dardonville C; Tidwell RR; Carrington M; O'Neill P; Boykin DW; Zachariae U; De Koning HP
    Elife; 2020 Aug; 9():. PubMed ID: 32762841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Front-line glioblastoma chemotherapeutic temozolomide is toxic to Trypanosoma brucei and potently enhances melarsoprol and eflornithine.
    Steverding D; Rushworth SA
    Exp Parasitol; 2017 Jul; 178():45-50. PubMed ID: 28552794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput decoding of antitrypanosomal drug efficacy and resistance.
    Alsford S; Eckert S; Baker N; Glover L; Sanchez-Flores A; Leung KF; Turner DJ; Field MC; Berriman M; Horn D
    Nature; 2012 Jan; 482(7384):232-6. PubMed ID: 22278056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of trypanocidal activity of combinations of anti-sleeping sickness drugs with cysteine protease inhibitors.
    Steverding D
    Exp Parasitol; 2015; 151-152():28-33. PubMed ID: 25662707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into antitrypanosomal drug mode-of-action from cytology-based profiling.
    Thomas JA; Baker N; Hutchinson S; Dominicus C; Trenaman A; Glover L; Alsford S; Horn D
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006980. PubMed ID: 30475806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Trypanosoma brucei MRPA in melarsoprol susceptibility.
    Alibu VP; Richter C; Voncken F; Marti G; Shahi S; Renggli CK; Seebeck T; Brun R; Clayton C
    Mol Biochem Parasitol; 2006 Mar; 146(1):38-44. PubMed ID: 16343658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of trypanocidal drugs used for human African trypanosomosis against Trypanosoma lewisi.
    Dethoua M; Nzoumbou-Boko R; Truc P; Daulouède S; Courtois P; Bucheton B; Cuny G; Semballa S; Vincendeau P
    Parasite; 2013; 20():39. PubMed ID: 24139487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymes of the trypanothione metabolism as targets for antitrypanosomal drug development.
    Schmidt A; Krauth-Siegel RL
    Curr Top Med Chem; 2002 Nov; 2(11):1239-59. PubMed ID: 12171583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melarsoprol- and pentamidine-resistant Trypanosoma brucei rhodesiense populations and their cross-resistance.
    Bernhard SC; Nerima B; Mäser P; Brun R
    Int J Parasitol; 2007 Nov; 37(13):1443-8. PubMed ID: 17602691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanosoma brucei: lack of cross-resistance to melarsoprol in vitro by cymelarsan-resistant parasites.
    Scott AG; Tait A; Turner CM
    Exp Parasitol; 1997 Jul; 86(3):181-90. PubMed ID: 9225768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance in human African trypanosomiasis.
    Barrett MP; Vincent IM; Burchmore RJ; Kazibwe AJ; Matovu E
    Future Microbiol; 2011 Sep; 6(9):1037-47. PubMed ID: 21958143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melarsoprol sensitivity profile of Trypanosoma brucei gambiense isolates from cured and relapsed sleeping sickness patients from the Democratic Republic of the Congo.
    Pyana Pati P; Van Reet N; Mumba Ngoyi D; Ngay Lukusa I; Karhemere Bin Shamamba S; Büscher P
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3212. PubMed ID: 25275572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current chemotherapy of human African trypanosomiasis.
    Docampo R; Moreno SN
    Parasitol Res; 2003 Jun; 90 Supp 1():S10-3. PubMed ID: 12811544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanothione as a target in the design of antitrypanosomal and antileishmanial agents.
    Augustyns K; Amssoms K; Yamani A; Rajan PK; Haemers A
    Curr Pharm Des; 2001 Aug; 7(12):1117-41. PubMed ID: 11472257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antitrypanosomal drug melarsoprol competitively inhibits thiamin uptake in mouse neuroblastoma cells.
    Szyniarowski P; Bettendorff L; Schweingruber ME
    Cell Biol Toxicol; 2006 May; 22(3):183-7. PubMed ID: 16555002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of melarsen-resistant Trypanosoma brucei brucei with respect to cross-resistance to other drugs and trypanothione metabolism.
    Fairlamb AH; Carter NS; Cunningham M; Smith K
    Mol Biochem Parasitol; 1992 Jul; 53(1-2):213-22. PubMed ID: 1501641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ebsulfur is a benzisothiazolone cytocidal inhibitor targeting the trypanothione reductase of Trypanosoma brucei.
    Lu J; Vodnala SK; Gustavsson AL; Gustafsson TN; Sjöberg B; Johansson HA; Kumar S; Tjernberg A; Engman L; Rottenberg ME; Holmgren A
    J Biol Chem; 2013 Sep; 288(38):27456-27468. PubMed ID: 23900839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.